By November 28, 2026: Billing and clinical staff must review the revised clinical criteria for all 45 affected drugs (CC-0002, CC-0010, CC-0024, CC-0027, CC-0029, CC-0033, CC-0042, CC-0048, CC-0051, CC-0063, CC-0072, CC-0087, CC-0092, CC-0094, CC-0101, CC-0102, CC-0105, CC-0106, CC-0107, CC-0108, CC-0111, CC-0114, CC-0116, CC-0124, CC-0130, CC-0143, CC-0145, CC-0153, CC-0158, CC-0160, CC-0162, CC-0165, CC-0169, CC-0175, CC-0188, CC-0201, CC-0206, CC-0207, CC-0209, CC-0225, CC-0240, CC-0252, CC-0262, CC-0264, CC-0274, CC-0276, CC-0281, CC-0284, CC-0285, CC-0294, CC-0299, CC-0302) on Anthem's Clinical Criteria page and document any changes to medical necessity requirements. Before November 28, 2026: Contact Anthem directly for authorization requirement details via their email contact method. Update provider encounter templates and billing system documentation requirements to reflect new/revised medical necessity criteria. Communicate changes to all clinical staff prescribing these medications. Failure to comply with updated medical necessity criteria will result in claim denials for non-compliant submissions.